Gating by ionic strength and safety check by cyclic-di-AMP in the ABC transporter OpuA by Sikkema, Hendrik R et al.
 
 
 University of Groningen
Gating by ionic strength and safety check by cyclic-di-AMP in the ABC transporter OpuA
Sikkema, Hendrik R; van den Noort, Marco; Rheinberger, Jan; de Boer, Marijn; Krepel,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Sikkema, H. R., van den Noort, M., Rheinberger, J., de Boer, M., Krepel, S. T., Schuurman-Wolters, G. K.,
Paulino, C., & Poolman, B. (2020). Gating by ionic strength and safety check by cyclic-di-AMP in the ABC
transporter OpuA. Science Advances, 6(47), [eabd7697]. https://doi.org/10.1126/sciadv.abd7697
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Sikkema et al., Sci. Adv. 2020; 6 : eabd7697     18 November 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
1 of 12
S T R U C T U R A L  B I O L O G Y
Gating by ionic strength and safety check by  
cyclic-di-AMP in the ABC transporter OpuA
Hendrik R. Sikkema1, Marco van den Noort1, Jan Rheinberger2, Marijn de Boer1,  
Sabrina T. Krepel1, Gea K. Schuurman-Wolters1, Cristina Paulino2*, Bert Poolman1*
(Micro)organisms are exposed to fluctuating environmental conditions, and adaptation to stress is essential for 
survival. Increased osmolality (hypertonicity) causes outflow of water and loss of turgor and is dangerous if the 
cell is not capable of rapidly restoring its volume. The osmoregulatory adenosine triphosphate–binding cassette 
transporter OpuA restores the cell volume by accumulating large amounts of compatible solute. OpuA is gated by 
ionic strength and inhibited by the second messenger cyclic-di-AMP, a molecule recently shown to affect many 
cellular processes. Despite the master regulatory role of cyclic-di-AMP, structural and functional insights into how 
the second messenger regulates (transport) proteins on the molecular level are lacking. Here, we present high- 
resolution cryo–electron microscopy structures of OpuA and in vitro activity assays that show how the osmoreg-
ulator OpuA is activated by high ionic strength and how cyclic-di-AMP acts as a backstop to prevent unbridled 
uptake of compatible solutes.
INTRODUCTION
Hypertonic stress of bacteria triggers a rapid uptake of K+ ions and 
uptake or synthesis of compatible solutes, which restores the turgor 
(1). The opposite stress, hypotonicity, can lead to cell lysis, which is 
mitigated by membrane tension–gated mechanosensitive channels 
that rapidly expel osmolytes and reduce the turgor (2). Compatible 
solute transporters that respond to hypertonic stress are gated by 
ionic strength or K+ ions (3–6), but recent studies have shown that 
the second messenger cyclic-di-AMP can also act as a key regulator 
of osmoregulatory transport (7–9). OpuA is a type I, ATP (adenosine 
triphosphate)–binding cassette (ABC) transporter (10) that belongs 
to a large family of osmoregulatory proteins, named BusA, OpuA, 
OpuC, OtaA, or ProU, present in bacteria and archaea. OpuA from 
Lactococcus lactis, the best-studied member, mediates the ATP- 
driven import of the compatible solute glycine betaine and is gated 
by ionic strength (11, 12), but mechanistic insights are still elusive.
Cyclic-di-AMP was first discovered as a messenger involved in 
the initiation of DNA damage checkpoints (13) but is also involved 
in central metabolism, cell wall metabolism, and, importantly, cru-
cial for the response of bacterial cells to osmotic stress (7, 14–17). 
While cyclic-di-AMP is essential for survival of bacteria, high con-
centrations of the molecule are toxic. Higher eukaryotes do not syn-
thesize cyclic-di-AMP, but the ER (endoplasmic reticulum) adapter 
protein (ERAdP) binds the molecule, which triggers a nuclear 
factor B–induced inflammatory cytokine release (18). Here, immune 
cells detect invading microbes through the presence of second mes-
sengers such as cyclic-di-AMP. Cyclic-di-AMP inhibits the transcrip-
tion of genes of osmoregulatory transporters including those of the 
opuA operon (19) and binds to a subset of cystathionine--synthase 
(CBS), RCK (regulators of K+ conductance), and USP (universal 
stress protein) domains of osmoregulatory proteins (8, 9, 16), indicating 
distinct levels of regulation. Although those studies have shown the 
importance of cyclic-di-AMP as a signaling molecule and structures of 
isolated CBS domains have been determined (8, 9), no structure of 
any transporter in complex with cyclic nucleotides is yet available.
RESULTS AND DISCUSSION
Functional properties of OpuA
OpuA is a homodimeric protein complex, wherein each protomer is 
composed of two polypeptide chains, with the transmembrane 
domain (TMD) fused to the substrate-binding domain (SBD) and the 
nucleotide-binding domain (NBD) fused to a tandem CBS domain 
(CBS1 and CBS2) (Fig. 1A). To mimic a native-like lipidic environ-
ment, OpuA was reconstituted in membrane scaffold protein 1D1 
(MSP1D1) nanodiscs for functional characterization and single- 
particle cryo–electron microscopy (cryo-EM) analysis. Different 
OpuA/MSP1D1/lipid ratios were tested, and a ratio of 1:10:500 was 
found optimal, using a lipid composition of 50 mole percent (mol %) 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 38 mol % 
1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG), and 
12 mol % 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). The 
adenosine triphosphatase (ATPase) activity of the transporter was 
determined with a coupled enzyme assay, where the ATP hydrolysis 
is stoichiometrically coupled to the reduced form of nicotinamide 
adenine dinucleotide (NADH) oxidation (Fig. 1B). In this lipid 
composition, OpuA is fully functional and gated by ionic strength 
(Fig. 1, C to F) (11). The ATPase activity of OpuA is tightly depen-
dent on the presence of glycine betaine (Fig. 1C), indicating that the 
activities in distant protein domains are mechanistically tightly 
coupled. The apparent half-maximum effect of glycine betaine on 
ATPase activity of 5.4 ± 0.7 M is very similar to the reported 
Michaelis constant (Km) of 1.9 M in proteoliposomes (20). The 
activation by ionic strength (11) is reflected by an increase in 
ATPase activity at increasing KCl concentration (Fig. 1D). OpuA is 
also regulated by cyclic-di-AMP (Fig. 1, C to E), with an apparent 
half-maximum effect for cyclic-di-AMP on the ATPase activity in 
the low micromolar range (Fig. 1E). Furthermore, the apparent Km 
for ATP hydrolysis of 4.5 ± 0.5 mM (and cooperativity upon ATP 
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binding with a Hill coefficient of 1.4 ± 0.1) (Fig. 1F) is comparable 
to the Km of ~3 mM reported for proteoliposomes (21). We con-
clude that OpuA retains full functionality after reconstitution in 
lipid nanodiscs.
Architecture of OpuA
To gain insight into the transport cycle, we have determined struc-
tures of full-length OpuA in nanodiscs in different conformations 
by single-particle cryo-EM. In the absence of substrate and at high 
ionic strength, an inward-facing (IF) conformation of wild-type 
OpuA was captured at 3.3 Å resolution, representing an apo state 
(Fig. 2A and fig. S1). This IF conformation shows variable spacing 
between the two NBDs (the different opening angles for different 
classes are visible in fig. S1D), hinting at a dynamic sampling of 
distinct degrees of NBDs opening in the apo state. As expected, the 
SBDs and CBS domains are not resolved in this state, most likely 
due to their high flexibility in the absence of the substrate glycine 
betaine and the CBS ligand cyclic-di-AMP.
An occluded conformation, with the transmembrane helices in 
an outward-oriented fashion, was obtained in the presence of 10 mM 
MgATP, 100 M glycine betaine, and at high ionic strength, when 
the catalytic glutamic acid in the NBD was mutated to a glutamine 
(E190Q) (Fig. 2B and fig. S2). The structure reveals that one of the 
SBDs is docked onto the TMD. It disrupts the twofold symmetry of 
the transporter, resulting in a cryo-EM map at a global resolution of 
3.4 Å, but allows an unambiguous modeling of the SBD and the re-
spective anchoring helix. Excluding the SBD and imposing a C2 
symmetry during image processing further improved the resolution 
to 3.2 Å in the remaining regions. The ATP-bound NBDs are arrested 
in a dimerized closed state, incapable of hydrolyzing the nucleotide 
because of the E190Q mutation (Fig. 2C). The CBS domains remain 
flexible and are, therefore, not resolved in the occluded state, which 
is consistent with the finding that a large part of the CBS domain is 
natively disordered and connected to the NBD via a linker region 
(22). The belt protein MSP1D1 wraps tightly around OpuA (fig. 
S3A), yet OpuA is fully active with comparable kinetics, as in proteo-
liposomes (Fig. 1, C to F), indicating that the nanodiscs do not perturb 
transport function.
A unique structural feature found in the cryo-EM maps is a do-
main that surrounds the TMD, hereafter referred to as the scaffold 
(Figs. 1A and 2D). It is covalently linked to the TMD and consists of 
two amphipathic  helices that are lying on top of the outer mem-
brane leaflet and two transmembrane-spanning helices that serve as 
lipid membrane anchors. By contrast, topology prediction pro-
grams located the amphipathic  helices on the intracellular side. 
To exclude a reconstitution artifact, we labeled OpuA in intact cells 
by introducing cysteine residues in the amphipathic  helices and 
used Cys325 in the NBD as negative control. We find that Cys23 and 
Cys24 in the first amphipathic  helix of the scaffold are accessible 
for the membrane-impermeable fluorescein-5-maleimide, whereas 
Cys325 is not, indicating that the amphipathic helices are, as revealed 
by the structures, indeed present on the outside (fig. S3B). Guided 
by the sequences of homologous proteins with and without the scaf-
fold, we deleted this domain but found OpuA inactive (fig. S3C). 
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Fig. 1. Domain organization of OpuA and activity in nanodiscs. (A) Left, SDS–polyacrylamide gel electrophoresis (PAGE) analysis of OpuA in nanodiscs; right, domain 
organization of OpuA protomers. (B) Schematic of the coupled enzyme assay to monitor ATPase activity, as shown in (C) to (F). LDH, lactate dehydrogenase; PK, pyruvate 
kinase. For (C) to (F), the standard assay mixture was composed of 50 mM K-Hepes (pH 7.0), 450 mM KCl, 4 mM phosphoenolpyruvate, 600 M NADH, 2.1 to 3.5 U of pyru-
vate kinase, and 3.2 to 4.9 U of lactate dehydrogenase. (C) ATPase activity of OpuA in nanodiscs in the presence of 10 mM ATP with (black circles) and without (blue triangles) 
10 M cyclic-di-AMP. (D) ATPase activity of OpuA in nanodiscs as a function of ionic strength (generated by addition of KCl) in the presence of 100 M glycine betaine and 
10 mM ATP with (black circles) and without (blue triangles) 10 M cyclic-di-AMP. (E) ATPase activity of OpuA in nanodiscs as a function of the cyclic-di-AMP concentration 
in the presence of 100 M glycine betaine and 10 mM ATP. (F) ATPase activity of OpuA as a function of the ATP concentration in the presence of 100 M glycine betaine. 
We normalized the ATP hydrolysis activities, as described in Materials and Methods. The error bars represent the SD of three technical replicates. PEP, phosphoenolpyru-
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Next, we analyzed by single-molecule fluorescence resonance energy 
transfer (smFRET) whether the scaffold undergoes conformational 
changes during the transport cycle. We stochastically labeled Cys24 
with Alexa Fluor 555 and Alexa Fluor 647 maleimide dyes and used 
alternating laser excitation (ALEX) of OpuA nanodiscs in solution (23) 
to monitor the FRET signal, which provides a measure for the dis-
tance between the residues. The FRET signals were virtually identi-
cal for all tested conditions: (i) high salt, (ii) low salt, (iii) turnover 
conditions, and (iv) turnover conditions in the presence of cyclic-
di-AMP (Fig. 2E). Further, no notable structural differences in the 
scaffold were found when comparing the IF and occluded confor-
mation (Fig. 2D). We therefore hypothesize that the scaffold has a 
static role and might provide stability, be involved in the docking of 
the SBD, or thin the membrane locally (24) to facilitate wider IF 
conformations and enable the NBD or CBS domain to interact with 
the membrane.
Substrate loading of OpuA
From x-ray structures of the isolated SBD domain from OpuA (25) 
and other proteins, it is known that the SBD changes its conforma-
tion upon substrate binding from open to closed (Fig. 3A) and sub-
sequently docks onto the TMD. However, our cryo-EM studies of 
OpuA in the presence of glycine betaine indicate that the substrate 
alone is not enough to trap the SBD in a (stable) docked state (fig. 
S4). Furthermore, in the occluded conformation, we do not find 
density for glycine betaine in the SBD. We observe a twist-like con-
formational change in the open-docked SBD, similar to the distortion 


















0.00 0.25 0.50 0.75 1.00
0





Occluded (3.4 Å) 












Fig. 2. Conformational states of OpuA during the transport cycle. (A) Cryo-EM map of the apo inward-facing conformation of wild-type OpuA at high ionic strength 
[50 mM KPi (pH 7.0) and 200 mM KCl (pH 7.0)] in the absence of glycine betaine. The NBDs are highly flexible, exposing different opening angles, as emphasized by the 
gray arrow. The SBD and CBS domains are not resolved. (B) Cryo-EM map of the substrate-loaded occluded conformation of OpuA (E190Q) in the presence of 100 M 
glycine betaine, high ionic strength [20 mM Hepes (pH 7.0) and 300 mM KCl], and 10 mM MgATP. The CBS domains are not resolved. (A and B) The color code of the indi-
vidual domains of one protomer is the same as in Fig. 1, and membrane boundaries are indicated by black lines. (C) ATP (blue sticks with phosphates in orange) bound to 
the NBD in the occluded conformation. Walker A, walker B, and signature motifs are shown in yellow (WA), red (WB), and green (C motif), respectively (density around ATP 
is shown as mesh at 6). Glutamine-190 is shown as stick. (D) Superposition of the scaffold that is covalently linked to the TMD of OpuA of both the IF (yellow) and occluded 
(green) conformation. (E) Single-molecule fluorescence resonance energy transfer (smFRET) measurements by alternating laser excitation (ALEX) of Alexa555- and 
Alexa647-labeled OpuA (S24C) in 20 mM K-Hepes (pH 7.0) at high ionic strength (+300 mM KCl), low ionic strength, turnover conditions [300 mM KCl, 10 mM MgATP, and 
1 mM glycine betaine (GB)], and turnover-inhibited conditions [300 mM KCl, 10 mM MgATP, 1 mM glycine betaine, and 100 M cyclic-di-AMP]. The dashed line marks the 
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transporter MetNI (26). This results in a disruption of the cation- 
interactions between the three tryptophan residues in the bind-
ing pocket of the SBD and glycine betaine (Fig. 3A), potentially 
squeezing the substrate out of the SBD into a pocket in the TMD. At 
the entry to the TMD, we find two highly conserved phenylalanines 
and two methionines that might interact with glycine betaine during 
translocation (Fig. 3B). In the IF conformation, these residues are 
pointing upward, spaced by ~10 Å, potentially allowing glycine be-
taine to be coordinated in between, whereas in the occluded confor-
mation, they are turned by 90°, closing the putative substrate entry 
point.
We then examined the occluded conformation for other 
substrate-binding pockets and found indication for an occluded 
space in the TMD, just below the extracellular boundary of the 
membrane. The occluded space is surrounded by phenylalanine, 
isoleucine, and methionine residues, resulting in a highly hydro-
phobic environment that coincides with an unassigned density, 
likely that of glycine betaine (Fig. 3C). We reason that the hydro-
phobic nature of the binding pocket prevents tight interactions with 
glycine betaine, similar to what has been proposed for the vitamin 
B12 importer BtuCD-F (27) but different from the solvent-filled 
cavity in the membrane domain of the maltose importer MalFGK-E 
(28). Thereby, substrate release into the cytoplasm is facilitated, 
allowing the formation of large concentration gradients and the re-
quired accumulation of osmolyte to (sub)molar levels under hyper-
tonic stress (29).
Regulation of OpuA by ionic strength
A multiple sequence alignment on different ABC importers, guided 
by the OpuA structure, shows that the NBDs contain a helix-turn- 
helix motif (HTH), which is not present in homologs that are not 
regulated by osmotic stress (Fig. 4A). The motif is located in close 
proximity to the membrane, consists of two short  helices, and 
contains a series of positively charged residues that are conserved 
among osmosensing homologs (Fig.  4,  A  and  B). Moreover, the 
number of positively charged residues close to the membrane in the 
ABC transporters ProU and OpuA (Fig. 4A) corresponds qualita-
tively to the ionic strength activation threshold of the proteins 
(6, 30). The ionic gating in OpuA requires anionic lipids and is, 
thus, dependent on the surface charge of the membrane (6, 11, 22, 31). 
As revealed by the cryo-EM structures, we speculate that the posi-
tively charged residues on the HTH interact with the negatively 
charged lipids. To test this hypothesis, we constructed a mutant in 
which the positively charged KRIK motif was mutated to AAIA and 
compared the in vivo glycine betaine uptake activity over a wide range 
of osmotic (ionic strength) conditions. We find that the mutant has 
close to maximal activity at low ionic strength and is much less 
affected by hypertonicity than wild-type OpuA (Fig. 4C).
We have previously shown that truncation of the CBS module 
(11) and mutagenesis of cationic residues on the surface of the CBS 
domains (22) affect the ionic strength gating of OpuA and, to some 
extent, the anionic lipid dependence of transport. We have, thus, 
postulated that the ionic strength sensor would reside in the CBS 
(11). However, below, we show that the CBS domains with bound 
cyclic-di-AMP are too distant from the membrane surface to act as 
an anionic lipid-dependent ionic strength sensor. Yet, we consider 
it possible that in the absence of cyclic-di-AMP, when a large part of 
the CBS is natively disordered (22), the CBS may interact with the 
membrane or with the HTH motif on the NBD. Future smFRET studies 
may explain the apparent role of the CBS module in ionic strength 
gating. We now propose that the cationic patch of the HTH in con-
junction with an anionic membrane surface forms the osmosensor 
of OpuA. The interaction between these two partners is modulated by 
the ambient ionic strength and sets the on/off state of the transporter.
Regulation of OpuA by cyclic-di-AMP
The persistent question on how cyclic-di-AMP regulates the activity 


























Fig. 3. Substrate delivery and translocation in OpuA. For a global indication of 
the location with respect to the full map, consult Fig. 2B. (A) Comparison of the 
x-ray structures of the soluble/isolated OpuA-SBD in an open [yellow; Protein Data 
Bank (PDB) ID: 3L6G] and a closed substrate-loaded conformation (green; PDB ID: 
3L6H) to the docked conformation, as seen in the full-length occluded structure 
(blue). (B) Comparison of the substrate entry point in the TMD seen from the ex-
tracellular side, for the IF conformation (left) and the occluded conformation 
(right), with residues F142 and M233 presumably closing the substrate entry. (C) G 
seen from the membrane plane, showing F166 and M227 as well. Unassigned 
density found in the occluded space of the TMD of the occluded conformation is 










Sikkema et al., Sci. Adv. 2020; 6 : eabd7697     18 November 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 12
stimulates the ATPase activity, while retaining the same dependency 
on the substrate glycine betaine (Fig.  1C). We also show that 
cyclic-di-AMP has no impact on the ATPase activity at low ionic 
strength (less than 250 mM KCl) (Fig. 1D). To elucidate the regula-
tory effect of cyclic-di-AMP, we reconstituted OpuA in vesicles 
together with a system for long-term metabolic energy conserva-
tion (Fig. 5A) (32). This approach allows us to monitor the impact 
of cyclic-di-AMP on substrate translocation, instead of ATPase 
activity alone. Notably, while we show that cyclic-di-AMP stimulates 
ATPase activity (Fig. 1E), we find that the same messenger inhibits 
glycine betaine uptake (Fig. 5B).
To obtain insights into the transport-inhibited state(s), we deter-
mined the structure of the full-length wild-type OpuA under 
turnover-like conditions (33), namely, at high ionic strength and in 
the presence of glycine betaine, adenylyl-imidodiphosphate (AMP-PNP) 
and cyclic-di-AMP (Fig. 5D and fig. S5). We find one of the SBDs 
docked onto the TMD in a substrate-bound (fig. S5H) closed con-
formation, different from the open-docked state seen for SBD on 
the occluded state (Fig. 2B). Although AMP-PNP is bound (fig. 
S5I), the transporter is stuck in an inward-facing state, rather than 
the outward-oriented conformation, as found for the occluded state 
of the E190Q mutant trapped in the presence of ATP. Further, we 
unambiguously resolve the structure of the CBS domain, with 
cyclic- di-AMP bound at the interface between the two tandem CBS 
domains (Fig. 5C) via a V-type interaction (15), which is different 
from the O-type interaction seen for the isolated CBS domains of 
the carnitine transporter OpuC (8, 19). The CBS domains are di-
merized via a crossover of the polypeptides, whereby the CBS 
domain of chain 1 interacts with the NBD of chain 2 and vice versa. 
We now find that the NBDs do not dimerize but are in close prox-
imity, presumably kept in this state by the CBS domain crossover 
(Fig. 5D).
Last, we determined another structure of OpuA at high ionic 
strength, in the presence of cyclic-di-AMP alone at 4.1 Å resolution 
(Fig. 5E and fig. S6). As expected, the SBDs are not resolved, but we 
find cyclic-di-AMP bound and the two NBDs in the same semi-
closed inward-facing state, as observed in the presence of glycine 
betaine plus AMP-PNP. We propose that the increased ATPase 
activity in the presence of cyclic-di-AMP (Fig. 1E) is caused by the 
close proximity of the NBDs. Yet, the CBS domain dimerization 
does not allow the transporter to open up completely to the intra-
cellular side, which might be required to release the substrate and/
or to allow for the SBD to undock and reset the transport cycle, 
explaining the inhibition of transport by cyclic-di-AMP (Fig. 5B).
Transport cycle of OpuA and conclusions
Using single-particle cryo-EM, complemented with smFRET studies 
and functional assays, we provide previously unknown insights into 
the structure, transport cycle, and regulation of OpuA, which is 
likely representative for other osmoregulatory ABC transporters 
(30, 34–36). The transport cycle starts with docking of the substrate- 
bound SBD to a transient narrow OF (outward-facing) conformation. 
Binding of ATP and dimerization of the NBDs lead to an outward- 
open state, where glycine betaine loads into a hydrophobic pocket 
in the TMD. Subsequently, ATP hydrolysis leads to a separation of 
the NBDs, which induces the transition to an inward-facing state. 
Full opening to the IF conformation releases the substrate to the 
cytoplasm and undocks the SBD, resetting the cycle (Fig. 6). 
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Fig. 4. Ionic strength sensor and ionic gating of OpuA. (A) Sequence alignment of part of the NBD with the putative ionic strength sensor. The top three sequences are 
OpuA homologs that are regulated by ionic strength; the bottom three sequences are nonregulated type 1 ABC importers. KRIK residues are shown in the blue box. 
Numbering is based on the OpuA sequence. UniProt IDs for the alignment are as follows: Ll-OpuAA, Q9KIF7; Bs-OpuAA, P46920; Lm-GbuA, Q9RR46; Ec-ProV, P14175; 
Ec-MetN, P30750; Cs-ArtN, Q8RCC2; and Ec-MalK, P68187. (B) HTH region of the NBD in the occluded conformation. The basic residues of KRIK are shown in stick repre-
sentation in blue. (C) In vivo 14C-glycine betaine uptake by wild-type OpuA (blue triangles) and the KRIK to AAIA mutant (black circles) as a function of osmotic stress 
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OpuA activity is controlled by a double brake on different sites, 
that is, ionic strength and cyclic-di-AMP. Hypertonicity increases 
the ionic strength inside the cell, which weakens the electrostatic 
interaction of the cationic HTH with the anionic membrane sur-
face. Under these conditions, OpuA is stimulated, which can lead to 
a massive accumulation of osmolytes, restoring the turgor and 
allowing the cell to cope with severe hypertonicity. However, once 
isotonic conditions have been reached, further uptake of osmolytes 
needs to be stopped to avoid the internal osmotic pressure reaching lytic 
values. It has been shown that uncontrolled OpuA can be lethal under 
low-osmolality conditions (7), indicating that regulation by ionic strength 
might not be precisely fine-tuned or too slow to stop uptake to (sub)
molar levels. Here, cyclic-di-AMP acts as a second gate to prevent 
unbridled uptake of glycine betaine and rescues the cell from lysis.
Inhibited inward-facing (4.1 Å)Inhibited inward-facing, 
SBD docked (3.5 Å)
(3.3 Å without SBD and C2 symmetry)











































Fig. 5. Regulation of OpuA by cyclic-di-AMP and proposed mechanism. (A) Schematic representation of OpuA reconstituted in vesicles together with the ATP- 
regenerating system described in (32). (B) Uptake of glycine betaine by OpuA in the vesicles in the presence (black triangles) or absence (blue circles) of 200 M cyclic- 
di-AMP. The ATP/ADP (adenosine diphosphate) ratio is kept constant (with ATP ~ 6.5 mM) by the co-reconstituted arginine breakdown pathway (32); error bars represent 
the SD of three independent experiments. (C) Binding site of cyclic-di-AMP in the substrate-bound cyclic-di-AMP–inhibited IF conformation of OpuA. Density around 
cyclic-di-AMP is shown as mesh at 6. We find one molecule of cyclic-di-AMP coordinated between both CBS domains. (D) Cryo-EM map of the substrate-bound 
inward-facing cyclic-di-AMP–inhibited conformation of OpuA in 20 mM K-Hepes (pH 7.0) at high ionic strength (+300 mM KCl) and in the presence of 10 M cyclic-di-AMP, 
10 M MgAMP-PNP, and 100 M glycine betaine. (E) Cryo-EM map of the IF cyclic-di-AMP–inhibited conformation of OpuA in 50 mM KPi (pH 7.0) at high ionic strength 
(+200 mM KCl) and in the presence of 10 M cyclic-di-AMP.
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Ionic strength gating Transport cycle Inhibition cycle
Fig. 6. Mechanism of translocation and regulation of transport. Schematic of the proposed transport cycle of OpuA. At low ionic strength, OpuA is in an inactive state. 
Ionic strength (~0.2 M) breaks the interaction of the sensor (cationic residues of HTH) with the anionic membrane and activates OpuA (gray shaded area). The transport 
cycle starts with a flexible IF. The substrate is bound by the SBD (blue), which docks onto the IF conformation. The substrate is translocated into the hydrophobic occlud-
ed space inside the outwardly oriented TMD (green). ATP hydrolysis returns the transporter to the IF conformation, and the substrate is pushed into the intracellular 
environment. The SBD undocks, resetting the transport cycle (unshaded area). In the inhibition cycle, the CBS domains (red) of OpuA dimerize by the binding of cyclic-di-
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Common chemicals were of analytical grade and ordered from 
Sigma-Aldrich Corporation, Carl Roth GmbH & Co. KG, or Merck 
KGaA. The lipids were obtained from Avanti Polar Lipids Inc. 
(>99% pure, in chloroform): DOPE (850725C), DOPC (850375C), 
and DOPG (840475C). n-Dodecyl--d-maltoside (DDM) (D97002) 
was purchased from Glycon Biochemicals GmbH and Triton X-100 
(T9284) from Sigma-Aldrich Corporation. 14C-glycine betaine was 
prepared enzymatically from 14C-choline-chloride [American 
Radiolabeled Chemicals Inc. (ARC 0208; 55 mCi mmol−1)], as 
described previously (6).
Expression of OpuA and preparation of membrane vesicles
L. lactis Opu401 containing pNZOpuAhis was cultivated semi- 
anaerobically at 30°C in a rich medium containing 2% (w/v) gistex 
LS (Strik BV, Eemnes, NL), 65 mM potassium phosphate (pH 7.0), 
supplemented with 1% (w/v) glucose, and chloroamphenicol (5 g ml−1) 
in a 10-liter bioreactor. The pH was kept at 6.5 with 4 M potassi-
um hydroxide. At an OD600 (optical density at 600 nm) of 2, the 
nisA promotor was activated by adding 0.05% (v/v) of the super-
natant of a nisin-producing strain (NZ9700) (37). After 2 hours of 
induction, the cells were harvested by centrifugation (15 min, 
6000g, 4°C) and resuspended in ice-cold 100 mM KPi (pH 7.0). The 
cells were centrifuged again and resuspended in 50 mM KPi (pH 7.0) 
to a final OD of 100 and stored at −80°C.
The cells were broken by two passes at 29,000 psi through a 
high-pressure device (Constant Systems) in the presence of 2 mM 
MgSO4 and deoxyribonuclease (DNase) (100 g ml−1), followed im-
mediately by the addition of 5 mM Na2-EDTA (pH 8.0) and 1 mM 
phenylmethylsulfonyl fluoride (PMSF). Cell debris was removed by 
centrifugation (15 min, 22,000g, 4°C), after which the membranes 
were spun down in an ultracentrifugation step (90 min, 125,000g, 
4°C). The membranes were resuspended to a total protein concen-
tration of 10 mg/ml in 50 mM KPi (pH 7.0) with 20% (w/v) glycerol, 
flash-frozen in liquid nitrogen, and kept at −80°C.
Purification of OpuA
Membrane vesicles containing OpuA were thawed and diluted to a 
total protein concentration of 3 mg/ml. OpuA was solubilized at 
4°C with 0.5% DDM for 60 min, after which the insoluble material 
was spun down (20 min, 270,000g, 4°C); 0.5 ml column volume of 
Ni2+-Sepharose resin was equilibrated with 12 column volumes of 
water and 2 column volumes of buffer [50 mM potassium phosphate 
(pH 7.0), 200 mM KCl, 15 mM imidazole, and 0.02% DDM]. The 
supernatant was diluted 2.5 times and incubated with the equilibrated 
resin for 1 hour at 4°C. The column was then poured, drained, 
and sequentially washed with 20 column volumes [50 mM potassium 
phosphate (pH 7.0), 200 mM KCl, 20% glycerol, 50 mM imidazole, 
and 0.02% DDM]. The protein was eluted in 0.6 column volume for the 
first and 0.4 column volume for the sequential fractions with elution 
buffer [50 mM potassium phosphate (pH 7.0), 200 mM KCl, 20% (w/v) 
glycerol, 500 mM imidazole, and 0.02% DDM]. The purified protein 
was directly used for reconstitution in nanodiscs or liposomes.
Labeling of OpuA and accessibility of scaffold domain
A small 30-ml M17 culture [with 2% (w/v) glucose and chloroam-
phenicol (5 g/ml)] was inoculated with L. lactis Opu401 contain-
ing pNZOpuAhis with one of the following cysteine mutations in 
the OpuA gene: Cys325 in the NBD, or Cys23, Cys24, or Cys25 in the 
first amphipathic helix of the scaffold domain. The cells were in-
duced at an OD600 of 0.5 to 0.6 with 0.05% (v/v) of the supernatant 
of a nisin A–producing strain (NZ9700) (37). The culture was grown 
for another hour and collected by centrifugation (15 min, 6000g, 
4°C); washed with 100 mM KPi (pH 7.5), 150 mM KCl, and 20 mM 
dithiothreitol (DTT); and centrifuged again (15 min, 6000g, 4°C). 
The cells were resuspended in 1 ml of the same buffer. For labeling, 
the cells were transferred to 2-ml Eppendorf tubes and centrifuged 
(3 min, 10,000g, 4°C) and washed twice in the same buffer without 
DTT. Fluorescein-5-maleimide (2 mM) in DMSO (dimethyl sulf-
oxide) was added (final DMSO concentration of 5%) and incubated 
at room temperature for 30 min. The reaction was stopped by addi-
tion of 20 mM DTT, and cells were collected by centrifugation (3 min, 
10,000g, 4°C) and resuspended in 100 mM KPi (pH 7.5), 150 mM KCl, 
and 20 mM DTT. Cells were lysed with glass beads in a TissueLyser 
(Qiagen) for 5 min at 50 Hz. Lysed cells were diluted 4× with 
100 mM KPi (pH 7.5), 150 mM KCl, and 20 mM DTT, and mem-
brane fractions were collected by ultracentrifugation (15 min, 
264,000g, 4°C), resuspended in 1 ml of the same buffer, and loaded 
on a 12.5% SDS–polyacrylamide gel electrophoresis (PAGE) gel. 
The gel was imaged on a LAS-3000 imager.
Purification of MSP1D1
The pMSP1D1 vector was freshly transformed into Escherichia coli 
BL21 DE3. The cells were grown aerobically in 1-liter baffled flasks 
using LB broth [1% (w/v) NaCl, 1% (w/v) bacto tryptone, and 0.5% (w/v) 
bacto-yeast extract with kanamycin (30 g/ml)]. At an OD600 of 
0.8, the cells were induced with 1 mM IPTG (isopropyl--d-1- 
thiogalactopyranoside). After induction, the cells were allowed to 
grow for 3.5 hours, after which they were harvested by centrifuga-
tion (15 min, 6000g, 4°C). The pellet was resuspended in 100 mM 
KPi (pH 7.8) and centrifuged again (15 min, 6000g, 4°C). After 
resuspending in the same buffer, the cells were stored at −80°C.
Cells were thawed on ice and supplemented with DNase (100 g/ml) 
and 1 mM PMSF. The cells were broken by sonication (70% ampli-
tude, total on time: 6 min; 5 s on, 5 s off). Triton X-100 [1% (w/v)] 
was added to the lysate and stirred at room temperature for 10 min. 
Unsolubilized material was spun down by centrifugation (30 min, 
30,000g, 4°C). Column volume (7.5 ml) of Ni2+-Sepharose resin was 
equilibrated with 4 column volumes of water and 4 column volumes 
of buffer [50 mM potassium phosphate (pH 7.8)]. The resin was 
incubated together with the supernatant for 1 hour at 4°C. The col-
umn was poured, drained, and washed sequentially with 4 column 
volumes of the following buffers: (i) 40 mM tris-HCl (pH 8.0), 
300 mM NaCl, and 1% Triton X-100; (ii) 40 mM tris-HCl (pH 8.0), 300 mM 
NaCl, 50 mM Na-cholate, and 20 mM imidazole; and (iii) 40 mM 
tris-HCl (pH 8.0), 300 mM NaCl, and 50 mM imidazole. MSP1D1 was 
eluted in 12 fractions of 2 ml with elution buffer [40 mM tris-HCl 
(pH 8.0), 300 mM NaCl, and 500 mM imidazole] and dialyzed overnight 
at 4°C against 20 mM tris-HCl, 100 mM NaCl, and 0.5 mM EDTA. 
MSP1D1 was then aliquoted, flash- frozen, and stored at −80°C.
Reconstitution of OpuA in MSP1D1 nanodiscs
For reconstitution in nanodiscs, different OpuA/MSP/lipid ratios 
were tested. For optimal conditions, 8.6 M purified OpuA was 
mixed with 86 M purified MSP1D1 scaffold protein and 4.3 mM 
lipids (with a composition of 50% DOPE, 12% DOPC, and 38% 
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glycerol and 12 mM DDM to a total volume of 700 l. After nutating 
the mixture for an hour at 4°C, 500 mg of SM-2 Bio-Beads (Bio-Rad) 
was added to adsorb the detergent. The mixture was then al-
lowed to incubate overnight. In the morning, the supernatant was 
separated from the Bio-Beads and the OpuA nanodiscs were puri-
fied by size exclusion chromatography using a Superdex 200 in-
crease 10/300 GL column in 50 mM potassium phosphate, 200 mM 
KCl, or 20 mM K-Hepes (pH 7.0) plus 300 mM KCl.
ATPase activity assays
As detailed in (12), the ATPase activity of the transporter was deter-
mined by a coupled enzyme assay where the NADH absorbance 
decrease at 340 nm is stoichiometrically coupled to the ATPase 
activity. The NADH absorbance is coupled to the ATP hydrolysis 
by the reactions catalyzed by pyruvate kinase and lactate dehydro-
genase (Fig. 1B); the enzymes in terms of activity were present in excess 
of OpuA. The assay was performed in 96-well plates. A Tecan Spark 
10-m plate reader was used to measure the NADH absorbance over 
time. Each well contains 50 mM Hepes (pH 7), 4 mM phosphoenolpy-
ruvate, 600 M NADH, 2.1 to 3.5 U of pyruvate kinase, and 3.2 to 
4.9 U of lactate dehydrogenase. The wells were then supplemented 
with 100 M glycine betaine, 300 mM KCl, 10 M cyclic-di-AMP, and 
10 mM MgATP unless specified differently. The 10 mM MgATP 
was used to start the reaction. In the case of variable ATP concen-
trations, the assay was started by titrating in 100 M glycine betaine. 
We normalized the ATP hydrolysis activities, and a value of 1 cor-
responds to 200 to 1200 nmol of ATP hydrolyzed per minute × 
nanomoles of OpuA, depending on the efficiency of nanodisc reconsti-
tution; for each set of experiments, the ATPase activity was normal-
ized to one condition that was identical in all biological replicates.
Cryo-EM sample preparation and data acquisition
Freshly prepared OpuA nanodiscs were concentrated to at least 
1 mg/ml using a Vivaspin 500 (50 kDa cutoff) concentrator. Before 
freezing, OpuA was diluted to 1 mg/ml and respective additives 
were added (e.g., 100 M glycine betaine, 10 M cyclic-di-AMP, 
10 M MgAMP-PNP, or 10 mM MgATP). Holey carbon grids 
(Quantifoil; Au R1.2/1.3, 300 mesh) were glow-discharged for 20 s 
at 5 mA. Sample (2.8 l) was applied on the grids, after which they 
were blotted for 3 to 5 s in a Vitrobot Mark IV (Thermo Fisher 
Scientific) at 15° to 22°C and 100% humidity and plunge-frozen 
into a liquid ethane/propane mixture. The grids were then stored in 
liquid nitrogen until further use.
Data collection was performed in-house on a 200-keV Talos 
Arctica microscope (Thermo Fisher Scientific) equipped with a K2 
and a post-column BioQuantum energy filter (Gatan) operated in 
zero-loss mode, with a 20-eV slit, and a 100-m objective aperture. 
Automatic collection was done at a calibrated magnification of 
49,407× (1.012 Å pixel size) and a nominal defocus range from −0.8 
to −1.9 m using EPU (Thermo Fisher Scientific). Holes were selected 
with the help of an in-house–written script that calculates ice thickness 
within DigitalMicrograph (Gatan). Each movie consisted of 60 frames 
with a total exposure time of 9 s and a dose of 53 electrons/Å2 
(0.883 e−/Å2 per frame). FOCUS software (38) was used for on-the-
fly quality control, and settings were adjusted if necessary.
Image processing
See figs. S1, S2, and S4 to S6 for a graphical overview on respective 
datasets. The following detailed description applies for the cryo-EM 
dataset acquired for the OpuA apo inward-facing sample, but a sim-
ilar workflow was used for the other datasets. A total of 2861 movies 
were recorded, and on-the-fly data assessment was conducted using 
FOCUS 1.1.0 (38). MotionCor2_1.2.1 (39) was used to correct for 
beam-induced motion, and ctffind4.1.8 (40) was used for estimation 
of the contrast transfer function (CTF) parameters. Micrographs 
containing ice or aggregates, micrographs with a low-resolution 
estimation of the CTF fit (>4 Å), and micrographs out of the defo-
cus range of 0.5 to 2 m were discarded. The remaining 2196 micro-
graphs were used for further processing. First, crYOLO 1.3.1 (41) 
was used to automatically pick 1,383,502 particles using a loose 
threshold. Particle coordinates were imported in RELION 3.0.8 
(42), and the particles were extracted with a box size of 256 pixels 
and binned 2×, yielding a pixel size of 2.024. A total of 786,018 par-
ticles were selected after several rounds of two-dimensional (2D) 
classification, to exclude false positives. For this dataset, an initial 
reference was generated in RELION. The particle set was further 
cleaned by several rounds of 3D classifications using the then cur-
rent best maps, low-pass–filtered to 40 Å, as references in an itera-
tive fashion. Both 2D and 3D classifications were performed, ignoring 
the CTF until the first peak. The resulting 434,607 particles from the 
best class(es) were re-extracted with a box size of 256 pixels and a 
pixel size of 1.012 and used for 3D autorefinement with the un-
binned 3D class as reference and, for later refinements, the refined 
map as reference, yielding a 4.0-Å map. A final 3D classification 
without image alignment was performed to separate different open-
ing angles, now with the reference low-pass–filtered to 20 Å. A total 
of 78,021 high-quality particles were used for 3D autorefinement. 
This refinement was continued as a focused refinement with a 
mask, excluding most of the lipid bilayer and the MSP1D1 belt pro-
tein, improving the resolution to 3.5 Å at convergence. C2 symme-
try was imposed during the latter autorefinement, and the obtained 
maps were used as subsequent references (low-pass–filtered to 40 Å) 
in an iterative fashion. Postprocessing was done to mask and sharpen 
the final map, yielding a resolution of 3.5 Å. Sequentially, several 
rounds of CTF refinement (42) were performed, using per-particle 
CTF estimation, increasing the resolution to 3.3 Å. Local resolu-
tions were determined using the RELION local resolution algo-
rithm. The 0.143 cutoff criterion (43) was applied for all resolution 
estimations, using gold-standard FSC (Fourier shell correlation) 
between both independently refined half-maps (44). The 3DFSC 
web server (45) was used to estimate directional resolution anisot-
ropy of the density maps.
Similar approaches were taken for the other datasets. In short, 
for the occluded dataset, 2759 movies were recorded and 2608 were 
used to select 572,496 particles. Several rounds of 2D and 3D classi-
fications yielded 479,186 and 90,870 high-quality particles, respec-
tively. After sequential 3D autorefinement, CTF refinement, and 
postprocessing without imposed symmetry, the resolution was 
3.4 Å. A 3D classification without image alignment was performed 
to separate two different orientations of the SBD that were otherwise 
merged together. Both classes were independently refined (3.5 and 
3.6 Å, respectively), after which the nanodisc density was removed 
using particle subtraction. Both sets were recombined and used for 
a final refinement and postprocessing with a mask (3.4 Å). Notably, 
the docking of a single SBD disrupts the twofold symmetry of the 
transporter. While the unsymmetrized cryo-EM map at a global 
resolution of 3.4 Å allows an unambiguous modeling of the SBD 
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refinement and imposing a C2 symmetry during image processing 
further improved the resolution to 3.2 Å in the remaining regions.
For the glycine betaine–only dataset, 1713 movies were recorded 
and 901 were used to select 615,299 particles. Several rounds of 2D 
and 3D classifications yielded 172,260 and 30,077 high-quality par-
ticles, respectively. After sequential 3D autorefinement and post-
processing with imposed C2 symmetry, the resolution was 4.5 Å. 
CTF refinement did not improve the resolution further.
For the cyclic-di-AMP–inhibited inward-facing, SBD-docked 
dataset, 8804 movies were recorded and 7788 were used to select 
1,344,075 particles. Several rounds of 2D and 3D classifications 
yielded 303,810 and 110,161 high-quality particles, respectively. After 
sequential 3D autorefinement, CTF refinement, and postprocessing 
without imposed symmetry, the resolution was 3.5 Å; processing 
without the SBD and C2 symmetry applied yielded a 3.3-Å map.
For the cyclic-di-AMP–inhibited inward-facing dataset, 1517 
movies were recorded and 1066 were used to select 657,116 parti-
cles. Several rounds of 2D and 3D classifications yielded 133,761 
and 13,520 high-quality particles, respectively. After sequential 3D 
autorefinement, CTF refinement, and postprocessing with imposed 
C2 symmetry, the resolution was 4.1 Å.
Model building
The model building was done in COOT (46). The resolutions of the 
maps were of sufficient quality to unambiguously build the model 
(figs. S1, S2, and S4 to S6 and table S1). The TMD was de novo built, 
while for the SBD, known crystal structures [Protein Data Bank 
(PDB): 3L6G and 3L6H] were used as reference (25). For the NBD, 
the structure of the homolog methionine transporter MetNI (PDB: 
6CVL) was used as a starting point (26). The CBS domain was built 
with the carnitine transporter OpuCA CBS domain (PDB: 5KS7) as 
reference (8). The models were optimized by iterative rounds of 
Phenix real-space refinement (47) and manual inspection and cor-
rections of the output models against the map in COOT.
Fourier shell cross-correlation (FSCsum) between model and 
map was used to determine the quality of the fit. To prevent poten-
tial overfitting, random shifts (up to 0.5 Å) were applied to the 
coordinates of the final model, followed by refinement against the 
first unfiltered half-map. This provided FSCwork, and the FSC 
against the second half-map, which was not used at any point 
during refinement, FSCfree, should have a marginal gap between 
them, indicating no overfitting of the model. MolProbity (48) was 
used to validate the chemo-physical properties of the final model. 
Images were prepared with the PyMOL Molecular Graphics System, 
version 2.0 Schrödinger LLC, Chimera (49), and ChimeraX (50). In 
addition, the SBGrid (51) software package tool was used to manage 
the software packages.
Labeling of OpuA for smFRET
Stochastic labeling was performed with the dyes Alexa555 and 
Alexa647 maleimide (Thermo Fisher Scientific). OpuA (5 to 10 nmol) 
was first treated with 10 mM DTT for 10 min to fully reduce oxi-
dized cysteines. After dilution of the protein sample to a DTT con-
centration of 1 mM, the reduced protein was immobilized on 200 l 
of Ni2+-Sepharose resin and washed with 2 ml of buffer A [20 mM 
K-Hepes (pH 7.0) and 300 mM KCl] to remove the DTT. The resin 
was incubated in 1 ml of buffer A supplemented with 50 nmol of 
Alexa555 and 50 nmol of Alexa647 for 2 to 4 hours at 4°C. Subse-
quently, unbound dyes were removed by washing the column with 
3 to 4 ml of buffer A. Elution of the proteins was done by supple-
menting buffer A with 200 mM imidazole. The labeled protein was 
further purified by size exclusion chromatography (Superdex 200, 
GE Healthcare) using buffer A. Sample composition was assessed by 
recording the absorbance at 280 nm (protein), 559 nm (Alexa555), 
and 645 nm (Alexa647) to estimate the labeling efficiency. The 
labeling efficiency was typically about 70%.
smFRET
Solution-based smFRET and ALEX (52) experiments were carried out 
at 5 to 25 pM labeled protein at room temperature in buffer A supple-
mented with additional reagents, as stated in the text and previously 
described (53). Microscope cover slides (no. 1.5H precision cover 
slides, VWR Marienfeld) were coated with bovine serum albumin 
(BSA; 1 mg/ml) for 30 to 60 s to prevent fluorophore and/or protein 
interactions with the glass material. Excess BSA was subsequently 
removed by washing and exchanged with buffer A. All smFRET 
experiments were performed using a home-built confocal microscope. 
Briefly, two laser diodes (Coherent OBIS) with emission wavelengths 
of 532 and 637 nm were directly modulated for alternating periods 
of 50 s and used for confocal excitation. The laser beams were cou-
pled into a single-mode fiber (PM-S405-XP, Thorlabs) and collimated 
(MB06, Q-Optics/Linos) before entering an oil immersion objective 
[60×; NA (numerical aperture) of 1.35; UPlanSAPO 60XO, Olympus]. 
The fluorescence was collected by excitation at a depth of 20 m. 
Average laser powers were 30 W at 532 nm (~30 kW/cm2) and 
15 W at 637 nm (~15 kW/cm2). Excitation and emission light were 
separated by a dichroic beam splitter (zt532/642rpc, AHF Analy-
sentechnik), which is mounted in an inverse microscope body 
(IX71, Olympus). Emitted light was focused onto a 50-m pinhole 
and spectrally separated (640DCXR, AHF Analysentechnik) onto 
two single-photon avalanche diodes (TAU-SPADs-100, PicoQuant) 
with appropriate spectral filtering (donor channel, HC582/75; ac-
ceptor channel, Edge Basic 647LP; AHF Analysentechnik). Regis-
tration of photon arrival times and alternation of the lasers were 
controlled by an NI card (PXI-6602, National Instruments).
Analysis of the photon arrival times was done as described in 
(54). Briefly, to identify fluorescence bursts, a “dual-channel burst 
search” (55) was used, as done previously (54). Three photon counts 
per burst were measured: NDA (acceptor emission upon donor 
excitation), NDD (donor emission upon donor excitation), and NAA 
(acceptor emission upon acceptor excitation) and assignment are 
based on the excitation period and detection channel (52). The photon 
counts were corrected for background, as done previously (56). The 
apparent FRET efficiency was calculated as NDA/(NDA + NDD), and the 
stoichiometry S was calculated as (NDA + NDD)/(NDA + NDD + NAA) 
(52). Binning the detected bursts into 2D apparent FRET versus 
stoichiometry histograms allowed the selection of the donor- and 
acceptor-labeled molecules and reduce artifacts arising from fluo-
rophore bleaching (52). The selected 1D apparent FRET histograms 
were fitted with a Gaussian distribution, using the method of least 
squares, to obtain a 95% confidence interval for the mean.
Co-reconstitution of ArcD2 and OpuA in liposomes
On the basis of the method described in (57), synthetic lipids were 
mixed from chloroform stocks in the ratio of 50 mol % DOPE, 
12 mol % DOPC, and 38 mol % DOPG, after which they were dried 
in a rotary vacuum setup (Büchi Labortechnik AG). The dried lipids 
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KPi (pH 7.0) with 200 mM KCl. Last, the mixture was sonicated 
using a tip sonicator (Sonics and Materials Inc.) (16 cycles, 70% am-
plitude, 15 s on, 45 s off) and frozen-thawed three times in liquid 
nitrogen. The liposomes were diluted five times to a final lipid con-
centration of 4 mg/ml after which they were destabilized by titrating 
with 10% Triton, until 60% of the initial absorbance after Rsat was 
reached (57). The proteins and destabilized liposomes were mixed 
to obtain a ArcD2:OpuA:lipid ratio of 1:2:400 (w/w). After 15 min 
of mixing at 4°C, the detergent was removed by adding four por-
tions of 200 mg of SM-2 Bio-Beads (10 mg of SM-2 Bio-Beads/mg 
of lipids) after 15-, 30-, 45-min, and overnight incubation. The last 
addition was followed by 2 hours of incubation at 4°C, after which 
the proteoliposomes were collected by ultracentrifugation (2 hours, 
125,000g, 4°C). The proteoliposomes were resuspended to a final 
lipid concentration of 100 mg/ml in 50 mM KPi (pH 7.0).
Encapsulation of the arginine breakdown pathway
The enzymes needed for arginine breakdown and ATP (re)genera-
tion were incorporated in the vesicles as previously described (32). 
In short, the proteoliposomes (66 l, 6.6 mg of lipid) containing 
ArcD2 and OpuA were mixed in 50 mM KPi (pH 7.0) with 1 M 
ArcA, 2 M ArcB, 5 M ArcC1, 5 mM ADP (adenosine diphosphate), 
5 mM MgSO4, 0.5 mM ornithine, and, optionally, 10 M cyclic-di-
AMP in a total volume of 200 l; the final liposome concentra-
tion was 33 mg of lipid per milliliter. The final internal medium was 
composed of 50 mM KPi (pH 7.0) (plus 25 mM NaCl carried over 
with the purified ArcA, ArcB, and ArcC1) (32). The enzymes and 
metabolites were encapsulated by five freeze-thaw cycles in liq-
uid nitrogen. After that, the vesicles were extruded 13 times through 
a 400-nm pore size polycarbonate filter with a prewashed extruder 
in 100 mM KPi (pH 7.0) supplemented with 0.5 mM ornithine. The 
vesicles were collected by centrifugation (20 min, 325,000g, 4°C), 
resuspended in 100 mM KPi (pH 7.0) supplemented with 0.5 mM 
ornithine, and centrifuged again (20 min, 325,000g, 4°C). Last, the 
vesicles were resuspended to a final concentration of 165 mg of lip-
id per milliliter and kept on ice before use in the transport assays.
In vitro transport assays
As described in (32), the vesicles with encapsulated enzymes and 
metabolites were diluted to a final concentration of 1.67 mg ml−1 in 
100 mM KPi (pH 7.0) supplemented with 250 mM KCl and 180 M 
glycine betaine, of which 2% (mol/mol) was 14C-radiolabeled. The 
mixture was incubated for 30 min at 30°C, and a time zero point 
was taken. The internal ATP production was then started by the 
addition of 20 mM arginine, and samples of 50 to 100 l were taken 
at given time intervals (0 to 5 hours). Samples were immediately 
diluted in 2 ml of ice-cold quenching buffer [100 mM KPi (pH 7.0)] 
and filtered over 0.45-m pore size cellulose nitrate filters to stop the 
reaction. The filters were then washed with another 2 ml of the same 
buffer. Radioactivity on the filter was quantified by liquid scintillation 
counting using Ultima Gold MV scintillation fluid (PerkinElmer) 
and a Tri-Carb 2800TR scintillation counter (PerkinElmer). Although 
the pore size of the filters is larger than the diameter of the vesicles, 
more than 99% of the vesicles are retained (11).
In vivo transport assays
For in vivo uptake assays, cells from strain L. lactis Opu401 carrying 
the pNZOpuAHis or pNZOpuAhis_K16R17K19A plasmid were 
grown in M17 supplemented with 1% glucose and chloramphenicol 
(5 g/ml). Moderate OpuA expression was induced for 1 hour with 
1 10−3% (v/v) of the supernatant of a nisin-producing strain (NZ9700) 
[Kuipers et al. (37)]. Afterward, the cells were washed twice with, 
and subsequently diluted to an OD600 of 50 in, ice-cold 50 mM 
Hepes (pH 7.3). To get linear uptake curves, cells diluted to 0.4 mg 
of total protein per milliliter were pre-energized for 5 min at 30°C 
in buffer supplemented with 10 mM glucose. 14C-glycine betaine 
uptake was initiated with prewarmed 50 mM Hepes (pH 7.3), sup-
plemented with 10 mM glucose, 14C-glycine betaine (1 mM end 
concentration), and the required sucrose concentration. Acquisition 
of data points was done similar to what is described for the lipo-
some uptake measurements. Note that quenching of each reaction 
is done in an ice-cold isotonic buffer. Afterward, leftover cells were 
broken by shaking in the presence of glass beads (0.1 mm Ø). 
Approximately 20 g of the total protein fraction was loaded on gel. 
To get the membrane fraction, the broken cells were spun down for 
12 min at 14,202g at 4°C. The membrane fraction of 0.45 mg of total 
protein was loaded on gel.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/47/eabd7697/DC1
View/request a protocol for this paper from Bio-protocol.
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inward-facing, and OpuA-inhibited inward-facing SBD docked, have been deposited in the 
Electron Microscopy Data Bank under accession numbers EMD-11782, EMD-11783, 
EMD-11785, EMD-11784, and EMD-11786, respectively. The deposition includes the cryo-EM 
map, both half-maps, and the mask used for final FSC calculation. Raw cryo-EM data will be 
deposited in in the Electron Microscopy Public Image Archive (EMPIAR). Coordinates of four 
models, OpuA apo inward-facing, OpuA (E190Q) occluded, OpuA-inhibited inward-facing, and 
OpuA-inhibited inward-facing SBD docked, have been deposited in the Protein Data Bank 
with accession numbers 7AHC, 7AHD, 7AHE, and 7AHH, respectively.
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